Delivery Order SPE2DB20D2104-SPE2DB25FNBTX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,010.02 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on September 11, 2025, with a completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $3,228.25 delivery order on August 29, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively issued. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,525.67 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on September 26, 2025, with completion targeted for September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $2,419.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract with an ultimate completion date of June 17, 2025 will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a single-source procurement with no set-aside designation, issued under a competitive contracting mechanism. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency awarded a delivery order valued at $4,623.23 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens (0.5 mL units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,456.89 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price, competitively awarded delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $28,019.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on August 6, 2025, with completion scheduled for August 7, 2025. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a firm fixed price ceiling value of $6,097.91. This non-competitive delivery order is expected to be completed by August 26, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBTXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,181.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pens on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Mounjaro, a diabetes management medication, aligns with the company's established portfolio of therapeutic products supplied to federal military and veteran healthcare systems, including other diabetes medications and specialty pharmaceuticals across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/26/25 |